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“CLINICAL PROFILE AND OUTCOME OF PATIENTS WITH 
NEUROTOXIC SNAKE BITE” 
ABSTRACT: 
INTRODUCTION: 
 Snake bite is the common medical emergency in India which we are 
encountering in our day to day practice. Snake bite is the most common 
problem in rural area and peri-urban areas. It is an occupational hazard among 
agricultural workers. Worldwide, India is having the highest number of 
mortality due to snake bite. Most of the deaths in the snake bite are due to 
time delay in reaching the hospital. The outcome of snake bite mainly 
depends on time delay in reaching the hospital and ASV administration. 
Among those who presenting to the hospital lately there is increased 
incidence of respiratory failure, prolonged hospital stay. 
AIMS & OBJECTIVES: 
 To study the clinical profile of patients with neurotoxic snake 
bite. 
  To study the outcome of neurotoxic manifestations of snake bite 
in terms of recovery or death. 
 To correlate the outcome of neurotoxic snake bite with the 
following factors:  Time delay, Respiratory failure, Amount of 
ASV needed, Type of snake, Need for ventilatory support, 
Ventilator associated pneumonia.  
MATERIALS AND METHODS: 
 Patients admitted with of history of snake bite-selected for clinical 
study as per inclusion/exclusion criteria are subjected to detailed history 
taking and clinical examination after obtaining informed consent. Type of 
snake, site and number of bite, occupation, time delay in reaching the 
hospital, amount of anti snake venom needed, neurotoxic manifestations are 
recorded in detail. Routine blood investigations like complete hemogram, 
renal function tests, serum electrolytes, serum creatine kinase were done for 
all patients included in the study. 
 Respiratory failure and need for mechanical ventilation among the 
study group was noted. Clinical progression over the day is observed in terms 
of deterioration of illness, recovery, death.  
RESULTS: 
  In our study, we observed that majority of the victims were in 
the age group between 41-60 years. Most of them were males and from rural 
areas. Cobra envenomation was more common than other snakes. The most 
common neurological manifestation observed was ptosis, followed external 
ophthalmoplegia and neck muscle weakness. Prolonged ventilatory support 
had increased risk for VAP. Respiratory failure, time delay in reaching the 
hospital premises had significant effect on the outcome of the individual. 
Early treatment with ASV reduces the mortality. 
 
CONCLUSION: 
 Snake bite is a preventable health hazard. Health education and 
awareness among the people reduces the mortality. There should be a 
National standardized protocol for managing snake bite. It should be strictly 
followed even in the primary health centres to reduce the mortality and also to 
prevent the time delay in accessing the tertiary care centre. 
 
KEY WORDS:  Anti snake venom, ptosis, ventilator associated pneumonia. 
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INTRODUCTION 
 
     Snake bite is the common medical emergency in India which we are 
encountering in our day to day practice. Snake bite is the most common 
problem in rural area and peri-urban areas. Snake bite is preventable health 
hazard. 
   
 Worldwide, India is having the highest number of mortality due to snake 
bite. According to WHO the total number of bites is estimated to be around 
83,000 cases among these there were about 11,000 deaths. Most of the deaths in 
the snake bite are due to time delay in reaching the hospital. 
   
 There are about 236 snakes in number only 52 snakes are poisonous in 
India. Snake bite is an occupational hazard in farmers,plantation workers and 
outdoor workers. The large number of snake bite occur while the people 
walking at night or walking in bare foot or in early morning along road side. 
       
 Snake bite can be prevented by educating the people working in 
agricultural fields: should not walk in bare-foot and to wear protective gloves, 
by avoiding the harmful practices such as tourniquet application, herbal 
remedies, cutting and sucking the bitten area, quackery. These harmful practices 
are ineffective and dangerous too.   
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 The outcome of snake bite mainly depends on time delay in reaching the 
hospital and ASV administration. Among those who presenting to the hospital 
lately there is increased incidence of respiratory failure, prolonged  hospital stay 
and renal failure. 
       
 Current intensive work is done in the pathological, toxicological, 
pharmacological and immunological aspects of snake bite which led to the 
production of polyvalent and monovalent antisnake venom. 
    
 National snake bite protocol is presented as a solution based approach. It 
emphasises the need for behavioural change in community to educate the people 
about the occupational risks and reduction. It emphasised that the patient with 
snake bite with envenomation when treated with ASV has better outcome.  
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AIMS AND OBJECTIVES 
 
1. To study the clinical profile of patients with neurotoxic snake bite. 
2.  To study the outcome of neurotoxic manifestations of snake bite in 
terms of recovery or death. 
3. To correlate the outcome of neurotoxic snake bite with the 
following factors:                                     
o Time delay 
o Respiratory failure 
o Amount of ASV needed 
o Type of snake 
o Need for ventilatory support 
o Ventilator associated pneumonia.  
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REVIEW OF LITERATURE 
HISTORY: 
   Snakes are the worship of Dravidian people and object of reverence since 
time immemorial. Since snakes have the fascinating appearance and it has the 
ability to cause death had created the interest for biologists and toxicologists all 
over the world. 
     The word snake and serpent are interchangeable. The word Serpent is 
derived from Latin “serpens” meaning creeping. In India Sushrutha suggested 
the treatment for snake bite by ligating the area above the snake bite and 
cauterizing the wound with hot iron rod.6 
      Nicande (204-135 BC) Greek poet wrote a book named ‘Theriaca’, the 
book which contains the presentation and treatment of poisoning from animal 
toxins.9 
     Mithridates (132-63 BC) king of pontus, prepared antidote in roman 
pharmacy named ‘Mithridatum’ which consists of about 36 ingredients. 
Andromachus (AD 37-68) added some ingredients to Mithridatum by adding 
squills and opium to counteract all poisons and bites of venomous animals.13 
      Nobel and Schmidt in 1937 proved that the pits on vipers have 
thermoreceptors. Essex described symptoms of various snake bites in 1945.(21) 
Yang was the first person to describe cobra toxin in 1968.(22). Weiss used 
heparin to treat bites by Echis carinatus in 1973.(23)        
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EPIDEMIOLOGY: 
 WORLD: 
     Venomous snake bite is the most important global cause of human injury 
from venomous and poisonous animals of all types.(17). Snake bite 
envenomation is serious health problem in rural areas of tropical and sub-
tropical countries like Asia, Oceania, Africa and Latin America. About 4,21,000 
snake bite and 20000 deaths occur worldwide due to snake bite throughout the 
world every year(20). The most fundamental problem in Asia- pacific region is 
that the snake bite treatment usually lies in the hands of traditional or herbal 
practitioners, so majority of the snake bite victims die before reaching the 
hospital. 
 
INDIA: 
    Snake bite mortality rate in India is about 3.35. About 15,000 death occur 
due to snake bite in India annually according to Swaroop and Grab(1954). 
Majority of snake bite victims are usually in the age group of 11-50 years. 
Males are commonly affected than the females. 
           Snake bite is most commonly seen in rural,outdoor areas and most 
common occupation hazard among the farmers and plantation workers. Most 
commonly the snake bite occur during midnight or in the early morning. Most 
of the cases occur during the month of May and September. 
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     According to Sawai et al(1974) the most common site of bite being the 
lower extremities(68%) followed by upper extremity, among the lower 
extremity feet is the common site(41%). Death due to snake bite is common in 
children and young people this is in relation to the body surface area because in 
children large venom is injected into the body surface area.  
               
 According to Sawai et al Cobra is responsible for the most of the death 
and second most common is krait.(27). Mortality rate is low with vipers.  
Snakes responsible for bite were only identified in about 6% of the hospitalised 
persons. 
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SNAKES: 
Snakes belong to the  
              Class- reptiles  
              Order- Squamata 
              Sub-order- Serpents(Ophidia) 
        
 Snakes are classified on the basis of dentition, sensory organs, 
arrangement of scales, osteology, on basis of immunological study of their 
venom and serum protein. Snakes are mainly carnivorous mainly feeds on the 
animals. Snake are divided into three parts- head, elongated body and tail. Of 
these the body of the snake is fully covered with scales, scales are usually shed 
during the moulting periods periodically. Snakes are usually lethargic and blind 
during the moulting period. 
      Snakes will have only a skull and extended spinal column without any 
appendanges for locomotion, it’s the linear most of all the vertebrates. Snakes 
usually use four patterns of movement: 
 
 Lateral undulation 
 Concertina movement 
 Rectilinear movement 
 Side winding                               
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 Usually at rest their bodies remain in the coiled state, they never  remain 
stretched out. They usually locate their food by their sense of smell, sense of 
vision and thermo sensitivity. The body of the snakes are very much sensitive to 
vibration. They smell its food by means of its forked tongue which enables it to 
collect the airborne particles and later it passes the particles to the Jacobson’s 
organ. Some of the snakes have infrared sensitive receptors around the nostrils 
or eyes which helps in seeing the radiated heat that emitted from the prey and 
by means of that they easily locate the prey. 
          Snakes does not have the effect of creating and maintaining the body 
heat, this is because they are more common in tropical and warm desert areas, 
they are otherwise called as cold blooded animals. In tropical countries due to 
high temperature they are throughout the year both during day and night. 
         Snakes are classified according to their toxicity as poisonous and non-
poisonous. 
           There are about five families of poisonous snakes (Biggam and Wright) 
 Colubridae (tree snakes) 
 Elapidae (cobra and krait) 
 Hydrophidae (poisonous sea snakes) 
 Viperidae (Russell’s viper) and  
 Crotalidae (pit viper) 
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          Among these elapidae- cobra and krait is the most common poisonous 
snakes inhabiting India. Among these Crotalidae and colubdridae are not seen in 
India.  
          The “Big 4s” that had been a big threat to India are Indian krait(Bungarus 
caerulens), the common cobra (Naja naja), saw scaled viper (Echis carinatus) 
and russell’s viper( Viper russelii). 
        The most common non –poisonous snakes are natux piscator,rat 
snake,common whip snake,cat snake,wolf snake and Indian python. 
 
WHO classification of medically significant snakes: 
      As against the list of “Big 4s”, WHO categorised the snakes of medical 
importance into three main classes in 1981 according to the severity associated 
with snake bite. 
 
Class I: Commonly cause death or   serious   disability 
      Eg: cobra, saw scaled viper and Russell’s viper. 
Class II: Uncommonly causes bites   but are   recorded to cause serious 
effect(death or local necrosis) 
     Eg: common krait, hump    nosed pit viper, king cobra 
Class III: commonly cause bites but serious effects are very uncommon. 
     Eg: Lipped pit viper.      
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    The most common snakes which we encountered in our day to day 
practice and some of the characteristics of the snakes are listed below: 
Naja naja(Cobra): 
     It has an average length of about 1-2 meters and it is active during 
both day and night. It usually does not bite a non-moving person.  Colour varies 
from dark brown or black to yellowish white, Head is usually oblong shape and 
has truncated frontal shield, Head has a well defined spectacle mark and the 
hood has a dark spot on either side and two or more broad black cross bands 
present below the hood, Small fangs with a gutter is present, Lethal dose is 
about 120 mg, Cobras are not usually aggressive and usually escape when 
encountered in wild, They usually bite the humans when they accidentally step 
on it or under extreme provocation. 
 
                                          Figure 1- King Cobra 
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Common Krait: 
       It has an average length of about 1-1.75 meters and it is usually 
active during night. Fangs are usually short. They enter the human dwelling 
frequently. Lethal dose is about 2-3 mg. Colour varies from bluish black or 
bluish grey. There is increased tendency for nocturnal bites. 
Saw scaled viper: 
       It is the smallest among the four snakes and has an average length 
of about 30-80 cm. it is usually greyish brown in colour with lancet at the head. 
Lethal dose is about 5 mg. it is about 5 times more toxic than cobra and 16 
times more toxic than Russell viper. It produces violent rustling sound, very 
nervous snake and it usually strikes at slight provocation. It usually flings in air 
of about 30 cm to deliver the bite. 
Russell viper: 
         It has an average length of about 1-1.85 meters. Colour varies light 
brown to yellowish brown. Fangs are big erectile and canaliculated. Head has 2 
large black spots at the base and ‘V’ shaped mark with apex on the top of snout. 
Lethal dose is 150 mg. it is active in the evening and at night. If it gets injured  
it bites with great force. It produces a characteristic hissing sound which is 
usually heard at a distance of about 25 feet.     
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                                      Figure 2- Common krait 
 
                                       Figure 3 – saw scaled viper 
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                                  Figure 4- Russell’s viper 
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Identification of poisonous snakes: 
The poisonous snakes are identified by some characterstics as listed below: 
 In poisonous snakes, the tail is laterally compressed. 
 Pit viper is identified by means of ‘loreal pit’ which is present between 
the eye and nostril 
 Russell’s viper-  loreal pit and sub-caudals are double(15) 
 Viper- scales in the dorsal side of head are small. 
 Krait- upper part of head having small scales and large shield, absent 
loreal pit, it has a fourth infralabial shield in lower jaw 
 Cobra- head has both small and large shields in dorsal aspect and third   
supralabial shield between the nostril and eye   
17 
 
     Table 1-Differences between non-poisonous and poisonous snakes 
Features Non-poisonous Poisonous  
Fangs  Short and solid Grooved and long 
Teeth  Small tooth many in 
number 
Two long fangs 
Belly scales Small scales but 
incomplete 
Usually large scale 
covers the entire belly 
Habits  Non-specific Nocturnal 
Head scales Scales are large Small in case of viper 
Large scales 
 Pit viper- loreal 
pit present 
 Krait-four infra 
labials and 
central row of 
scales on the 
back 
 Cobra-third 
labial touches 
the eye 
Tail  No lateral compression Laterally compressed 
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 Figure 5- Differences  between the poisonous and non-poisonous snakes 
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Classification of  snakes based on fangs: 
         Fangs/ teeth helps the snakes in injecting the venom into the tissues of its 
prey. Spitting cobras are one type of cobra that squeezes the venom out of their 
fangs and ejects a fine spray which is directed towards the eyes of victim.(15) 
      There are four types based on their fangs. They are 
 Aglyphs 
 Opisthoglyphs 
 Solenoglyphs 
 Proteroglyphs 
 
Aglyphs: 
      Fangs are absent in this type of snakes, eg: non-venomous snakes 
Opisthoglyphs : 
         Fangs are present at the back of the mouth. Groove is present in the fang 
through which the venom flows. Eg:  tree snakes 
Solenoglyphs: 
    This type of snake is having the advanced biting apparatus, fangs are very 
long in these snakes. This venom usually act on the vascular system. When 
unused the biting apparatus are folded in the roof of mouth. Eg; viper and rattle 
snakes 
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Proteroglyphs: 
       Some of the snakes have grooves in the fangs and in others grooves are 
present in the sides which then unites to form a canal, which helps in effective 
delivery of the venom into the victim. This venom mainly acts on the nervous 
system.Eg; cobra  
 
Venom apparatus and its constituents: 
     Venom apparatus consists of  gland, duct and canal. Venom gland opens 
into the canal through the duct, venom canal is situated in front of the upper jaw 
in the fangs. Venom can be injected in either way by means of subcutaneous 
route or by intramuscular route. Snakes are capable of controlling the amount of 
venom injected during bite.  
 
 
 
 
 
 
 
  
                                       Figure 6-  Venom apparatus 
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       “Dry bites” are the bites in which the snake bites the person without 
injecting the venom. Reason for dry bite can be due to snake voluntarily retends 
the venom or when the snake bites through the clothing or when the snake bites 
through an unnatural angle. 
Venom helps the snake in digestion and immobilisation of the prey. 
Snake venoms consists of many proteins(60-90). 
 
FIGURE 7- MECHANISM OF VENOM ACTION  
. 
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The components of the snake venom are 
1. Enzymes 
2. Non-enzymatic polypeptides  
3. Non toxic proteins 
 
ENZYMES: 
 Proteinases- due to proteolytic action it causes tissue damage 
 Hyaluronidase- It produces edema and swelling of the adjacent areas 
 Phosphatase- causes reduction in blood pressure 
 Acetylcholine esterase- has effect on neuromuscular junction and heart 
muscle 
 Phospholipases-produces haemolysis by means of secreting lysolecithin 
 Arginine esterase hydrolase- coagulant action. 
 5’ nucleotidase- hydrolyses the phosphate monoesterase, active 
phosphatase in the venom. 
NON-ENZYMATIC POLYPEPTIDES: 
     Non- enzymatic peptides are responsible for the mortality, because the 
components of non-enzymatic peptides are 
o Hemorrhagins 
o Neurotoxin and  
o Cardiotoxin 
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 Hemorrhagins  
      It exerts its effect by means of releasing histamine and serotonin which 
causes vasodilation and interrupting the basement membrane produces vascular 
damage and haemorrhage. It produces haemorrhage in heart,lungs,brain 
,gastrointestinal tract and kidneys. 
 
 Cardiotoxin 
         It acts on the cell membranes and produces effects on cardiac, smooth 
and skeletal muscles, neuromuscular junction thereby producing circulatory 
failure, muscle paralysis, cardiac asystole and respiratory failure. This is 
because the cardiotoxin causes irreversible depolarization of cell membrane 
transporters and produces cardiac asystole by releasing the calcium from the 
surface of the myocardium. 
 
 Neurotoxin: 
      It acts by blocking the neuromuscular transmission in either of the two 
ways, by means of producing alpha and beta  bungarotoxin. Alpha bungarotoxin 
produces effect similar to that of d-tubocurarine by means of acting on the 
motor end plate post-junctionally by blocking the neuromuscular junction by 
means of anti-depolarisation. This effect can be reversed by neostigmine.   
      Beta- bungarotoxin produces effect similar to that of botulinium toxin. It 
produces neuromuscular blockade by means of acting pre-synaptically thereby 
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it reduces the acetyl choline output. The blockade mainly dependant on the 
frequency of nerve stimulation. 
       Snake  Venom exhibits different degree of toxicity, this is mainly 
dependant on the species of the snake, amount of venom injected, multiple 
bites, size of snake, one or two fangs penetrated the skin, mechanical efficiency 
of bite. 
 
CLINICAL FEATURES OF ENVENOMATION: 
      Symptoms and signs of snake bite varies from person to person, which 
depends on the following features
41
  
SPECIES: mainly depends on the symptoms of presentation 
VICTIM’S SENSITIVITY: varies from person to person 
AGE: younger people exhibits more toxic features compared to adults 
SITE, DEPTH AND NUMBER OF BITES:  More proximal the bite the 
rapidity of spread of venom is high. More the depth of the bite, fatality rate is 
more because of the fast spread of venom into the blood stream. 
DEGREE AND KIND OF FIRST AID TREATMENT: Time delay in 
reaching the hospital and practice of some unwanted things and having 
treatment in the local practitioners increases the mortality of the patient. 
AMOUNT OF VENOM: Biting through the clothes, bitten after recent prey 
will introduce only  the  small amount of venom. 
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FIGURE 8: CLINICAL MANIFESTATIONS OF SNAKE BITE 
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      Symptoms can be classified into either due to the local effects in the 
bitten area and systemic effects due to the toxin 
  
LOCAL SYMPTOMS: 
 PAIN:   
         Pain is more severe in case of viper, usually occurs within 5-10 
minutes. Burning sensation at the site of bite occurs due to cobra which 
usually occurs within 15-30 minutes. Some non-poisonous snakes like 
fresh water snake and rat snake cause severe pain at the bitten area. 
 SWELLING: 
         Swelling due to viper usually starts within  minutes of bite, this 
is because the venom mainly act on the hemostatic system. It usually 
subsides within 2-3 weeks. In case of cobra swelling occurs in the 
period between 1-3 hours, it  is usually tender. Krait and non-
poisonous snakes doesn’t produce local swelling. 
 ECCHYMOSIS AND ERYTHEMA: 
            Cobra bite produces a dusky discolouration which extends in 
area and darkens in colour. Around third or fourth day the pigmented 
area is surrounded by red raised rim and when you incise the rim, it 
releases red material and shows the necrosis of the underlying tissue. 
In case of viper the discolouration is due to the extravasation of RBCs 
into the subcutaneous tissue, it is usually confined to the bitten area. 
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 HEMORRHAGIC BULLAE AND VESICLES: 
           It is present in  case of viper and cobra. Vesicles usually occur 
within 8-36 hours. In viper bites, if the blisters extending upto the limb 
denotes that  large amount of venom is injected. 
  NECROSIS: 
           Wet gangrene occurs in case of cobra, it is because of the direct 
cytolytic effect of the venom. Necrosis occurs rapidly in case of cobra. 
Dry gangrene occurs in case of viper, necrosis occurs due to the 
ischemia. Necrosis is mainly superficial very rarely it involves the 
tendons,muscles,bones. 
 BLEEDING FROM THE BITTEN AREA: 
           In viper there will be Continuous oozing from the bitten area. 
 FANG MARKS: 
            Absence of fang marks doesn’t exclude the snake bite. Two 
discrete puncture marks indicates the bite of venomous snake. 
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               Figure 9 – FANGS OF POISONOUS AND NON POISONOUS 
SNAKE 
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Figure 10 – Local envenomation with hemorrhagic blebs 
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SYSTEMIC SYMPTOMS: 
 
ELAPIDAE: 
       Presents with both neurotoxic and cardiotoxic manifestations. 
 
Neurotoxic manifestations: 
      Earliest symptom is drowsiness or intoxication which occurs from 15 
min- 3 hours. It has neuromuscular blockade action which affects the system in 
the orderly manner involving the muscles of eye,tongue,pharynx, chest and at 
last the limb muscles. The most commonest and earliest manifestation is the 
bilateral ptosis. Extra ocular movements are impaired producing diplopia or 
double vision. Due to palatal palsy the patient develops difficulty in speech, 
followed by dysphagia. In case of severe poisoning the patient develops 
respiratory paralysis which manifests as tachycardia, tachypnoea, confusion, 
hypotension, shallow breathing and stupor. Limb weakness occurs very late. It 
manifests as complete flaccid quadriplegia with intact bowel and bladder 
functions. 
 
Cardiotoxic manifestations: 
                 Symptoms usually will occur within 30 minutes due to cardiotoxin, 
symptoms occur very rapidly. It mainly causes cardiovascular depression which 
31 
 
presents as cold extremities, hypotension, sweating, tachycardia and sometimes 
have ECG changes seen in the ST segment and T wave. Very rarely the patients 
have cardiac arrthymias and cardiac asystole. 
 
 
              Figure 11- Patient with bilateral ptosis and external 
ophthalmoplegia
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Cobra- spit ophthalmia:  
       Spitted venom from the cobra enter into the eyes of victim produces 
intense persistent  burning sensation,pain, inflamed conjunctiva, photophobia, 
watering of the eyes, swelling of eyelids, blurring of vision and blindness on 
temporary basis. Sometimes it produces permanent vision loss by producing 
corneal ulceration, secondary endophthalmitis and scars in the cornea which is 
mainly seen in the African people not in case of Asians. 
 
                                    Figure 12- spit ophthalmia 
VIPER: 
          It exhibits some non-specific symptoms which is due to the direct effect 
of venom by means of activating the kinin system. It occurs within few minutes 
of bite which includes headache, explosive diarrhoea, vomiting and abdominal 
pain, these symptoms resolves spontaneously within 30-60 minutes. 
       Haemorrhage is the classical presentation of viper envenomation. 
Diagnostic and earliest symptom is the uncontrolled bleeding from the bitten 
area with hemorrhagic bleb. 
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       Systemic hemorrhagic manifestations include hematuria, hemoptysis, 
hematemesis, malena, bleeding from the gums, cerebral haemorrhage. 
Haemorrhage into the vital organs or in the brain or retroperitoneum is usually 
fatal.  
          
 According to Reid et al (1963) hemoptysis is the earliest and commonest 
manifestation which can be seen as early as 20 minutes. 
          
 Shock is the main cause of death in case of viper. Shock occurs due to 
several factors which includes hypovolemia due to loss of  plasma and  blood 
into the bitten area, pulmonary intravascular clotting, cardiac effects, pulmonary 
edema and serum enzyme levels.  
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                 Figure 13-  Algorithm for  Identification of snakes based on 
clinical symptoms
35 
 
COMPLICATIONS OF SNAKE BITE: 
        It includes  
 Renal failure 
 Gangrene 
 Compartment syndrome 
 Non-bacterial thrombotic endocarditis 
 Respiratory paralysis  
 Guillain barre syndrome 
RENAL FAILURE: 
        Direct cytotoxic effect of snake venom is suspected to cause acute kidney 
injury. Symptomatology includes oliguria and electrolyte and fluid imbalances. 
Renal biopsy of the snake bite shows either acute tubular necrosis or patchy and 
diffuse cortical necrosis. Interstitial nephritis, papillary necrosis and 
glomerulonephritis occur very rarely.(8) 
GANGRENE: 
      Cobra produces wet gangrene and viper produces dry gangrene. 
Secondary infection can occur in the necrotic debri.  
COMPARTMENT SYNDROME: 
       It mainly occurs in case of cobra bite. It is a very rare complication. It 
occurs due to the venom injection into the intramuscular plane. 
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NON-BACTERIAL THROMBOTIC BACTERIAL ENDOCARDITIS: 
     It usually occurs in patients with wasting disease, damaged valves due to 
intracardiac foreign body, marked turbulence. 
RESPIRATORY PARALYSIS: 
     It is seen in case of cobra and krait bite. The presentation in early stages 
include tachypnoea,confusion, tachycardia,stupor, coma, respiratory failure and 
death. Respiratory failure occurring in case of snake bite is mainly type-II 
respiratory failure. 
GUILLAINE-BARRE SYNDROME: 
      It is an unusual complication which occurs due to krait. Symptoms of 
symmetric paralysis and sensory signs, facial nerve involvement, autonomic 
dysfunction and elevated CSF protein can occur(14). Nerve conduction study 
reveals profound sensory and motor polyneuropathy. 
RARE COMPLICATIONS: 
 Sub arachnoid haemorrhage 
 Hypo-pituitarism(14) 
 Bilateral thalamic hematoma 
 Hysterical paralysis 
 Second degree heart block 
 Acute MI due to dyselectrolytemia 
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TABLE 2-IDENTIFICATION OF SNAKES BASED ON THE 
SYNDROMIC APPROACH 
 
Syndrome 
  
 
Species  
Local swelling with bleeding 
manifestation 
 
 
All viper 
Local swelling with respiratory 
paralysis 
 
 
Cobra  
Respiratory paralysis without local 
envenomation 
 
  
Krait  
Local swelling with 
bleeding/shock/renal failure 
 
 
Russell’s viper 
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FIGURE 14- SPECIES IDENTIFICATION IN SNAKE BITE  
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INVESTIGATIONS 
 The diagnosis is mainly based on the clinical findings.  
 20 minute WBCT: 
      It is usually performed at the bed side, very informative test. 
It doesn’t require any technical assistance. It is the most reliable test for 
coagulation. It is usually performed in a clean, dry, new glass vessel.  
          Few ml of blood should be drawn from the vein and sample 
is poured into the clean,dry test tube and it should be kept in the room 
temperature for 20 minutes. It should not be disturbed for 20 minutes and 
it should be gently tilted, it should not be shaken. The vessel should be 
clean and dry because the dirty tube/ when rinsed with detergent it will 
interfere with the clotting mechanism. After 20 minutes if the blood is in 
liquid state it is considered as incoagulable  blood. Incoagulable blood 
indicates the bite is due to viper. 
 Elevated WBC count indicates severe poisoning 
 Fibrinogen is decreased and FDP is increased in case of DIC 
 Serum lactate in case of acidosis 
 Serum enzymes: raised CPK- suggestive of skeletal muscle damage. 
 LFT: deranged in case of hemolysis with elevated levels of unconjugated 
bilirubin. 
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 Urine examination detects the microscopic hematuria in case of viper and 
myoglobin in case of sea snake poisoning. 
 Chest x ray: shows pulmonary haemorrhage in case of viper 
 ECG: ECG changes are unusual. ST-T changes, AV block can occur due 
to cardiotoxicity 
 CT brain: hemorrhages in the brain seen in case of fatal viper bites. It is 
seen very rarely. 
 Blood urea and creatinine: for assessing the renal function in case of viper 
 Serum electrolytes: serum potassium level may be elevated in case of sea 
snake poisoning 
 Retic count: increased in case of hemolysis 
 Peripheral smear examination: spherocytes, Heinz body and acanthocytes 
in case of hemolysis. 
 Fundus examination: for intra retinal or vitreal haemorrhage in case of 
severe viper bite. 
 RBC casts can be identified in urine sample, if the victim has associated 
glomerular injury. 
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MANAGEMENT: 
FIRST AID TREATMENT PROTOCOL: 
       Most effective way of giving first aid to the patient is shifting him to the 
nearest hospital as early as possible. 
        Our aim should be to preserve the life of the victim, reduce the absorption 
of venom, prevent complications before the victim reaches the hospital. But 
most of the methods carried at the level of the bitten area is mostly dangerous 
and ineffective. Giving reassurance for the patient and immobilising the limb 
are the two important first aid which can be done at the field level.(3) 
 
Recommended first aid method in India: 
               It is based on the mnemonic: 
                                 Do it R.I.G.H.T. 
     R-     Reassuance of the patients 
     I-       Immobilisation of the limb 
G.H.- get to hospital immediately 
T-      Tell to the doctor about the symptoms. 
 
 
 
 
 
42 
 
PRESSURE IMMOBILISATION METHOD (PIM):   
 This method is not applicable in India. This was first discovered by 
Sutherland in Australia in 1974. Application of  integral splint and crepe 
bandage at a pressure of 55 mm of mercury would reduce the absorption of 
venom. But it has limitation if the victim walks for 10 minutes with the splint 
this method is ineffective. Later in 1994, Howarth identified that the pressure 
for immobilisation in upper and lower limb is different. Lower limb pressure 
was about 55-70 mm of mercury and for upper limb is 40-70 mm of mercury. 
For the above constriants, this method is not applicable in India. 
 
MONASH TECHNIQUE/PRESSURE PAD: 
     To reduce the amount of venom entering into the system, hard pad of 
rubber is tightly applied to the wound. But this method is under research in 
India to assess the efficacy. This technique is highly useful in case of Indian 
armed forces.  
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                   FIGURE 15- PRESSURE IMMOBILIZATION (PIM)   
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SNAKE BITE TREATMENT PROTOCOL: 
   According to the national snake bite protocol, treatment for snake bite 
includes the  
 Diagnostic phase  
 Treatment phase 
 
DIAGNOSTIC PHASE: 
  Diagnosis: 
      Identification of species is important for clinical management. Diagnosis 
can be established by identifying the dead snake or by the syndromic approach.  
Sometimes the snake can be brought to the hospital by the relatives either dead 
or alive, which helps in identifying the species. Snakes should not be handled 
directly, because the bite reflex in the decapitated snake is highly uncontrolled, 
it can eject venom for as long as 1 hour after death(34) 
Non-venomous or venomous snake: 
     It is very important to differentiate between the venomous and non-
venomous bite and from other animals bite, it helps in treating the patient 
effectively. Fang marks are not diagnostic of snake bite but it is a highly 
sensitive sign. In the absence of positive identification, diagnosis is made from 
the symptoms and objective signs. (7) 
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Patient assessment: 
      Patient is quickly assessed for the airway, breathing and circulation.  All 
patients should be in observation for minimum of 24 hours. Antibiotic use is not 
routinely recommended, if the patient has cellulitis or necrosis antibiotics 
should be given. If the skin in the bitten area is broken, T.T. injection should be 
given.  
 
INDICATIONS FOR URGENT RESUSCITATION: 
 Profound hypotension and shock 
 Sudden cardiac arrest by hyperkalemia  due to sea snake bite 
 Renal failure  
 Septicaemia due to local necrosis 
 Respiratory failure 
 Sudden deterioration  occurs due to the sudden gush of venom entering 
into the systemic circulation 
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TABLE 3-CLINICAL FEATURES AND TREATMENT RESPONSE 
OF POISONOUS SNAKES (7) 
FEATURE KRAIT COBRA SAW 
SCALED 
VIPER 
RUSSELL 
VIPER 
HUMP 
NOSED 
VIPER 
Local pain/ 
tissue 
damage 
No  Yes  Yes  Yes  Yes  
Hemostatic 
abnormalities 
No  No  Yes  Yes  Yes  
Renal 
complications 
No  No  No  Yes  Yes  
Ptosis/ 
neurological 
signs 
Yes  Yes  No  Yes  No  
Response to 
neostigmine  
No  Yes  No  No  No  
Response to 
ASV 
Yes  Yes  Yes  Yes  No  
 
     24 hours observation is must for all the patients this is because of late 
onset of envenomation especially the hump nosed pit viper and krait causes late 
onset of symptoms, but this usually occurs between 6-12 hours. This is because 
when the juvenile snakes bite the victim in the thicker area of skin symptoms 
usually occur late. 
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GRADING OF SEVERITY OF ENVENOMATION: 
  
Grade  Fang 
marks 
Pain  Local 
symptoms 
Systemic 
symptoms 
0- No 
envenomation 
+/- No  No  No  
1- Mild 
envenomation 
+ Moderate  Erythema, 
Edema <15 
cm 
No  
2- Moderate 
envenomation 
 
+ 
Severe  Ecchymosis, 
erythema, 
edema 15-30 
cm  
Nausea, 
Vomiting, 
syncope, 
thrombocytopenia,  
anaemia, weakness 
3- Severe 
envenomation 
+ severe Edema>30c
ms, 
Erythema, 
Ecchymosis, 
Blisters 
Hypotension, 
Respiratory failure, 
Coma, 
Paraesthesia. 
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ANTI-SNAKE VENOM(ASV): 
 It is the only specific treatment available for snake bite. ASV was 
introduced  at institute Pasteur in 1890 by Albert Calmette. Anti venom is 
purified from the plasma of horse, donkey, sheep which had been immunised 
with venom of one or more species. It is immunoglobulin, it is an enzyme 
refined F(ab)2 fragment of Ig G. ASV is available in both lyophilised and liquid 
forms. Lyophilised in powder form,only to be kept cool, highly useful form in 
remote areas where the power supply is inconstitent.  Usually hospitals will 
have the lyophilised forms for long term storage of ASV. Liquid ASV requires a 
proper cold chain for maintaining the efficacy and has a shelf life of about 2 
years. 
 
TYPES OF ASV: 
  It can be either monovalent or polyvalent antivenom. Monovalent 
antivenom is effective against single snake. Polyvalent antivenom neutralises 
the venom of several species of snakes 
 
COMPOSITION: 
     Every vial should be restituted with 10 ml of sterile water and the it 
contains the following constituents: 
 Cobra                           -0.6 mg 
 Russell viper                -0.6 mg 
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 Common krait              -0.45 mg 
 Saw scaled viper          -0.45 mg 
 Preservative: cresol I.P. – 0.25% 
 Stabiliser                       - glycine I.P 
 Excipients                     - mannitol and sodium chloride   
         
 ASV is helpful if it is given within 4 hours of the bite, it is of less value 
when it is given at 8 hours, and is of doubtful value when it is given after 24 
hours. 
 
ASV manufacturers in India 
: 
 VINS bio-products, Hyderabad 
 Serum institute of India, Pune  
 Biological E, Hyderabad 
  Haffkine bio- pharmaceuticals corporation, Mumbai 
 Bengal chemicals and pharmaceuticals, Kolkata 
 Bharat serums and vaccines, Mumbai 
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They produce about 1 million vials annually. Assuming an average dose of 10 
to 20 vials per envenomed victim, current capacity exists to treat 50,000 to 
1,00,000 envenomed patients on yearly basis in India. 
 
 
INDICATIONS FOR ASV: 
Signs of  Systemic envenomation-   
           Neurotoxic features- muscle paralysis, ptosis, neck muscle weakness, 
external ophthalmoplegia 
          Coagulopathy- prolonged WBCT, spontaneous systemic bleeding 
          Cardiovascular manifestations- abnormal ECG, arrythymias, 
hypotension,shock 
          Persistent vomiting and abdominal pain 
          Acute kidney injury- rising creatinine, oliguria and anuria 
Signs of local envenomation-  
        Local swelling in the bitten area when it involves more than half of the 
limb 
       Rapid extension of swelling 
       Enlarged lymph node in the bitten area 
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MODES OF ADMINISRTATION OF ASV: 
     It can be given either by subcutaneous or intramuscular or intravenous 
route. Subcutaneous and intramuscular route is not usually preferred route. 
Intravenous route is the most commonly encountered route of administration of 
ASV. Local injection of ASV at the site of bite is not usually recommended, as 
it increases the risk of compartment syndrome. 
 
 Intravenous route 
It is the most preferred route of administration, it can be administered in two 
methods as follows, intravenous push technique or intravenous infusion. 
1. Intravenous “ push” injection-  Highly Economical, should be 
given by slow intravenous infusion, should not be given more than 
2ml/min.  This method  has the merit that early reactions due to 
ASV can be observed and can be treated early also. 
2. Intra venous infusion-  ASV is diluted in 5-10 ml/kg body weight  
of isotonic fluid, and infused at a constant rate for about 1 hour. 
During this period they are monitored closely for early 
anaphylactic reactions. 
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 Intramuscular route: 
Bioavailability of  anti venom is very poor in case of intramuscular route, 
absorption is also slow in case of i.m. route because the antivenoms are large 
molecules. Disadvantages of  i.m. route are pain in the injection site and 
hematoma occurs in case of viper bite. 
 
Dosage of ASV:  
 Initial dose of the ASV should be administered to neutralise the venom 
injected during the bite. The venom injected during the initial bite is expected to 
be 5 mg- 140 mg, which makes the required dose between 10 -25 vials which 
neutralises 6-8 mg of Russell’s viper. Half life of anti snake venom is about 90 
hours. 
The treatment protocol followed in our hospital is as follows: 
 For hemotoxic snake bite- initial 8 vials, dose should be repeated  if the 
bleeding persists or clotting time is not normalised . Later 5+5+5 vials 
should be given.(8+5+5+5 vials) 
 For neurotoxic snake bite- initial  8 vials  should be given and  next dose 
should be given in 2 hours if there is no clinical improvement and if the 
patients  develops neurotoxic manifestations. Later 8+5 vials of ASV 
given(8+8+5 vials) 
 For local envenomation- Initially 8 vials of ASV vials given. 
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     Test dose should not be administered for ASV.  Test dose is not of any 
value in preventing the reactions, instead it pre-sensitises the individual and 
poses greater risk. ASV should be slowly administered in initial one hours and 
the patient needs to be monitored for 2 hours. 
      The dose of ASV in children is similar to that of adults i.e, same dose as 
that of adults.  ASV is mainly to neutralise the venom, amount of venom 
injected by the snake is same in case of children and adults.  In case if the 
individual presents late to the hospital with complications like renal failure, role 
of ASV is questionable. Do 20 minutes  WBCT for that patient and if it is 
prolonged, ASV can be given. If not means, treat the renal failure by means of  
hemodialysis. ASV only acts if the venom is unattached form in the circulation.   
 
Contra indication for ASV:  
 Per se there is no absolute contraindication for ASV administration. In 
case of atopic patients ASV should be given only if the patient developed signs 
of systemic envenomation. 
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MANAGEMENT OF SNAKE BITE IN SPECIAL SITUATIONS: 
 
1. Children  
        Dose of ASV administered in case of children is the same 
dose as that of adults. The amount of venom injected by the snake 
is same as in case of adults. Mortality is more in case of childrens 
due to larger body surface area.(17) 
2. Pregnancy  
        Dosage is same as that given in normal individuals. There is 
no clear cut evidence that the venom crosses the placental barrier.  
It doesn’t have much influence on the outcome of the fetus, very 
rarely spontaneous abortion has been documented.  If necessary the 
patient can seek the opinion of the gynaecologist regarding the 
outcome of the fetus. 
 
ADVERSE REACTIONS OF ASV: 
    
 Adverse reactions of ASV are common and it may vary from minimal 
reactions to fatal anaphylaxis. Reactions are mainly complement mediated, not 
Ig G mediated. 
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It is usually of three types 
1. Early(anaphylactic reaction) 
2. Pyrogenic reactions  
3. Late (serum sickness type) reactions 
 
EARLY REACTIONS: 
        
 It usually occurs between 10-60 minutes after administration. Symptoms 
include tachycardia,itching,cough, urticaria, fever, nausea,vomiting,palpitation 
and headache.  Of these about 5% of the patients exhibit severe anaphylactic 
reactions in the form of broncho spasm, angioedema,hypotension, sometimes 
very rarely death. 
 
PYROGENIC REACTIONS: 
     
 These reactions are mainly due to endotoxins which usually occurs after 
1-2 hours after administration. Symptoms include initially they presents with 
chill with cutaneous vasoconstriction, goose flesh, shivering. Due to intense 
vaso-dilation, temperature rises steadily followed by fall in mean arterial 
pressure. Due to associated GI symptoms such as vomiting and diarrhoea 
patient experiences decrease in body temperature. 
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LATE(SERUM SICKNESS) REACTION: 
      
 It usually occurs after 7 days. Symptoms include itching, urticaria, 
arthralgia,albuminuria,lymphadenopathy, flu like symptoms with fever, 
neurological symptoms like mononeuritis multiplex, GBS very rarely 
encephalopathy. 
 
Management of ASV reactions: 
    
 Adrenaline 1 in 1000 in a dose of 0.5- 1 ml for adults and 0.01 mg/kg for 
children. It should be given by the subcutaneous route. In certain situations it 
can also be given by IM/IV/intracardiac route depending on the severity of 
reactions. Anti-histaminics shold be administered along with this. Oral steroids 
are given for late reactions(13) . 
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PROPHYLACTIC REGIMEN FOR ASV REACTIONS: 
     This is not routinely recommended. This regimen is mainly indicated for 
atopic individual or highly sensitised individual. 
   Two regimens are  used: 
1. 0.25-0.3 mg adrenaline 1:1000 given subcutaneously 
2. 100 mg of hydrocortisone and 10 mg of avil injection should be 
given before 5 minutes.  In children,  Anti- histaminics should be 
cautiously used. Dose in case of children is 2 mg/kg of 
hydrocortisone and 0.1-0.3 mg/kg of H 1 blocker.   
 
Neostigmine test: 
     
 Victims bitten by the cobra will respond to neostigmine very well. 
Initially atopine 0.6 mg should be given IV and followed by neostigmine should  
be given IM in the dose of 0.02 mg/kg for adults. Positive test includes that the 
patient will have improvement in the ptosis and ventilatory capacity will  
improve.(8)  Improved individuals should be maintained on 0.5 mg of 
neostigmine IM,0.6 mg of atropine IV for about 8 hours. 
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RECOVERY SIGNS: 
       
 If the patient had received the adequate dose of ASV, the patient will 
exhibit some signs of recovery following ASV administration. Signs seen in the 
patients showing recovery are 
 
 WBCT  should be restored within 6 hours. 
 BP increases after 30 minutes in case of hypotensives. 
 Spontaneous bleeding usually  arrests within 15-30 minutes. 
 In case of active hemolysis,rhabdomyolysis and urine returns to normal 
colour within few hours. 
 Neurotoxic manifestations of cobra bite improves within 30 minutes. 
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MANAGEMENT OF COMPLICATIONS: 
      
 Complications can arise in any phase of treatment. This should be 
managed in tertiary care centres. The complications include: 
1. Renal failure 
2. Severe bleeding 
3. Hypotension 
4. Sepsis  
5. Cardiac complications 
6. Compartment syndrome 
7. Neurological sequelae 
 
RENAL FAILURE: 
        
 It is seen in case of hump pit viper and russell viper. Renal failure occurs 
due to direct venom effect, rhabdomyolysis, hypotension,intravascular 
hemolysis,DIC. Renal failure is indicated by raising serum creatinine, reduced 
urine output in the form of oliguria/anuria, classical uremic syndrome, 
acidosis.(11) 
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 Hemodialysis or PD should be performed in the patients with features of 
acidosis, hyperkalemia, creatinine >4mg/dl,uremia. In case of rhabdomyolysis, 
acidosis should be corrected with bicarbonate, saline diuresis should be 
maintained. 
 
SEVERE BLEEDING: 
      
 Bleeding manifestations will usually be corrected with the ASV. Heparin 
and anti-fibrinolytics should not be given. In these patients, IM or SC injectin 
should be avoided. They should br treated with FFP, cryoprecipitate,platelets or 
whole blood. 
 
HYPOTENSION: 
     
 Hypotension may occur due to various reasons like cardiotoxicity, vaso-
dilatation due to venom, hypovolemia, ASV reaction, acute pituitary adrenal 
insufficiency in Russell viper. Hypotension should be treated with dopamine, 
vaso-constrictor in the starting dose of about 2.5-5mcg/kg/min. steroids are used 
in case of adrenal insufficiency. 
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CARDIAC COMPLICATIONS: 
     
 This is unusual and  rare complication. The manifestations include sinus 
arrthymia, bradycardia, tachycardia,gallop rhythm and AV block. If the rhythm 
disturbances are persistent, cardiologist consultant is must for managing the 
patient. 
 
COMPARTMENT SYNDROME: 
           
 Immobile, cold, swollen and pulseless limb indicates the compartment 
syndrome with increased intracompartmental pressure. It is characterised by the 
6Ps which includes pallor, paralysis, pulseless,pain on stretching the limb, pain 
out of proportion to swelling,paraesthesia.  This syndrome is less common in 
India. It can occur in case of cobra.  By using stryker pressure monitor intra 
compartmental pressure is measured. Criteria for fasciotomy in compartment 
syndrome includes when there is increased intracompartmental  pressure > 40 
mm of Hg, and if the patient is also having the clinical features of  
compartmental syndrome. 
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MANAGEMENT OF COBRA SPIT OPHTHALMIA: 
  
 It includes  
 Decontamination with copious amount of saline 
 Topical administration of 0.5% of adrenaline- relives pain and 
reduces inflammation 
 Topical cycloplegics  for relieving the  discomfort and ciliary spasm 
and for preventing the posterior synechiae formation 
 Topical anaesthetics- tetracaine which relieves the pain 
 In case of allergic conjunctivitis, antihistaminics are administered. 
 Topical anti venom should not be used .because it causes irritation of 
the eyes 
 Topical antibiotics are given for the corneal ulcer 
 
Neurological manifestations: 
      In case of diaphragmatic paralysis, patient should be provided invasive 
mechanical ventilation. This mainly occurs in case of cobra and krait bite. 
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PREVENTION: 
      Snake bite is the major problem in case of rural areas especially those 
who working in the fields.(17)  The major situational  source of bite is while 
cutting the grass. Majority of the bites occur during the night or in the early 
morning(18). Simple precautions should be taken to prevent the chance of 
getting snake bite, this is by means of understanding the habits about the snakes. 
 Avoid walking in bare foot in night 
 Use torch lights in night to avoid being bitten by the snake 
 Avoid sleeping in the ground 
 Walk with heavy steps in the night times this produces the 
vibration which keeps aside the snake 
 Keep the waste things away from the home, these things will 
attract the rat and snakes will enter the human dwellings in 
search of its prey  
 Use sticks to strike the base of the leaves while cutting the 
grasses 
 Never put your hands into the blind hole before inspecting 
 Keep plants away from the doors or windows.  
 Protective clothing like long trousers, socks and thick leather 
shoes should be worn 
 Never handle a dead snake in bare hands.  Because they 
continue to eject venom after one hour of decapitation 
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 Indoor toilets should be made compulsory for new house- 
bearers. This will avoid being bitten by the snake 
 Particular care should be taken while collecting the 
firewood,moving logs,boxes and trees covered with dense 
foliage 
 Venomous snakes should never be kept as pet or performing 
animals 
 Snakes should never be attacked, disturbed  
 
PROPHYLAXIS: 
 Venoids( venom toxoids) has been used to immunise the farmers who are 
at high risk. In some areas, there has been research going on for the production 
of venoid against Russell viper, this is because of early development of renal 
failure. 
      The production and modification of venom antigen by means of  genetic 
engineering leads to the production of snake venom vaccines. But these are 
under trail. 
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MATERIALS AND METHODS 
 
Study centre:   Poison centre, Institute of internal medicine, Rajiv Gandhi 
government general hospital, Chennai-3. 
Study design:   Retro and prospective study 
Sample size:    50 patients admitted with history of snake bite are analysed 
comprehensively. 
Duration of study: 6 months March 2014-August 2014 
 
Inclusion criteria: 
     Patients admitted with history of snake bite showing features of 
neurotoxic manifestations in the form of 
      Ptosis 
      Extra ocular movement restriction 
      Neck muscle weakness 
      Respiratory failure 
Exclusion criteria: 
1. Patients in cholinergic crisis 
2. Hypokalemia 
3. Flaccid paralysis 
4. Myasthenia gravis,myopathy. 
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METHODOLOGY 
Data collection and methods: 
      Patients eligible for study are subjected to detailed history taking and 
clinical examination. 
 
Methodology: 
       Patients admitted with of history of snake bite-selected for clinical study 
as per inclusion/exclusion criteria are subjected to detailed history taking and 
clinical examination after obtaining informed consent. Type of snake, site and 
number of bite,occupation,time delay in reaching the hospital,amount of anti 
snake venom needed,neurotoxic manifestations are recorded in detail. Routine 
blood investigations  like complete hemogram,renal function tests,serum 
electrolytes,serum creatine kinase  were done for all patients included in the 
study. 
         Detailed clinical examination will be done daily and close monitoring 
was done. Clinical progression over the day is observed in terms of 
deterioration of illness,recovery, death. Respiratory failure and need for 
mechanical ventilation among the study group was noted. 
 
 All patients included under the study were treated with anti-snake venom 
and other supportive measures. Mechanical ventilation were provided for 
68 
 
patients in respiratory failure. Patients in ventilator were assessed for the 
duration on ventilator and development of ventilator associated pneumonia. 
 
    They were followed till the end point of outcome either in the form of 
recovery or death. Outcome will be assessed with the following factors, 
 Type of snake that biting 
 Site of bite 
 Time delay in reaching hospital 
 Amount of anti snake venom needed 
 Respiratory failure 
 
Investigation details: 
 Serum creatinine kinase 
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Statistical analysis: 
          Statistical analysis was carried out for 50 patients after categorising 
each variable- Age, sex, occupation, place,time delay in reaching hospital,site of 
bite,amount of anti snake venom needed, respiratory failure and other clinical 
features and finally outcome. 
 
        Data were analysed using statistical package-SPSS software. The values 
are presented as mean, standard deviation, frequency of occurrence. Percentages 
were used to express the proportion of discrete variables. 
 
            The statistical significance was indicated by the  
 Chisquare(x2) test 
 Fisher exact test. 
               Variables were considered to be significant if P<0.05. 
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OBSERVATION & RESULTS 
 
Table 4 – Age distribution 
S.No Age group in years Frequency(n) 
 
Percentage  
1. 15-20 3 
 
6% 
2. 21-30 12 
 
24% 
3. 31-40 13 
 
26% 
4. 41-60 17 34% 
 
5. >60 5 10% 
 
Total 
  
 50  
 
In our study, 17 out of 50 patients were in the age group 
between 41-60 years. But this is not statistically significant 
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Figure 16-  Age distribution 
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Sex distribution 
            Among the 50 persons, 30 were found to be male and 20 were found to 
be females. 
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TABLE 5 . OCCUPATION AND OUTCOME 
 
S.No Occupation 
  
 Outcome   Total  
Recovery  Death  
1.  Agriculture 
  
28(65%) 7(14%) 35(70%) 
     2. Non- 
 
Agriculture 
  
15(35%) - 15(30%) 
  43(86%) 
 
7(14%) 50(100%) 
 
           70% of the cases were from agricultural sector and the remaining 30% of 
the cases from manual labourers and others. 
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Figure 17  - Occupation and Outcome 
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Table 6-   Place and outcome 
 
S. No. Place  Frequency 
(n)  
Percentage 
(%) 
  
Recovery  Death  
 
1. Rural 39 
 
78% 36 3 
2. Urban  11 
 
22% 7 4 
Total   50 
 
100% 43 7 
  
 
  Among the 50 victims, 78% of them are from rural area and the remaining 
22% are from urban area, in that 3 persons were died in the rural area and 4 
were in the urban area. 
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Figure 18 -  PLACE AND OUTCOME 
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          Table 7. TYPE OF SNAKE AND OUTCOME 
 
S.No Type of 
snake 
Frequency 
(n)  
Percentage 
 (%) 
Recovery  Death  
1. Cobra  24 48% 
 
20(83.3%) 4 
2. Krait  15 30% 
 
14(93.3%) 1 
3. Viper  11 22% 
 
9(81.8%) 2 
Total  50 100% 
 
43 7 
 
 
          24 patients were bitten by cobra, 15 cases by krait and 11 cases by viper. 
93% of the patients bitten by krait ,83% bitten by cobra and 81.8%  bitten by 
viper were recovered and this is stastically  insignificant( P-0.614)  
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Figure  19-TYPE OF SNAKE AND OUTCOME 
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TABLE  8 - SITE OF BITE AND OUTCOME 
S.No. Site of bite Frequency  
(n) 
Recovery  Death  
 
1. Upper limb 14 12 2 
 
2. Lower limb 32 28 4 
 
3. Others  4 3 1 
 
TOTAL 
 
 50 43 7 
 
  32 victims were bitten in the lower limb and 14 persons in the upper limb. 
According to this data, most common site of bite being the lower limb but this is 
stastically insignificant(P>0.05) 
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FIGURE 20-   SITE OF BITE AND OUTCOME 
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 Table 9 – TIME DELAY AND OUTCOME 
 
S.No Time delay Recovery  Death  Frequency  
(n) 
 1. <3 hours 20(47%) 1(14%) 21(42%) 
 
2. 3-6 hours 11(26%) 1(14%) 12(24%) 
 
3. >6 hours 12(28%0 5(7%) 17(34%) 
 
TOTAL  43(86%) 7(14%) 50 
 
 
 
Time delay in seeking the hospital treatment increases the mortality rate. 
Among the  7 persons who were dead, 5 cases were accessed  the hospital 
premises late and this is statistically significant with P value of about 0.01. 
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Figure 21  - COMPARISON BETWEEN THE TIME DELAY AND 
OUTCOME OF PATIENTS 
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TABLE 10  - RESPONSE TO NEO-STIGMINE 
 
Neostigmine response 
 
Frequency 
  (n)  
Percentage 
(%)  
Responder  24 
 
48% 
Non responder 26 
 
52% 
Total  50 100% 
 
       
       Of these 24 patients were responded to neostigmine while the remaining 26 
were non-responders. Neostigmine responders were found to be bitten by the 
cobra. 
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Figure 22-    RESPONSE TO NEOSTIGMINE 
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TABLE  11- DOSAGE OF ASV NEEDED 
 
S.No Dose of ASV needed Frequency 
(n) 
  
Percentage  
  (%) 
1. 16 vials 
  
15 
 
30% 
 
 
2. 23 vials 35 
 
 
70% 
Total   50  
 
 
 
 
Among the 50 patients, 35 of the cases  received ASV in the dosage of 23 vials 
and remaining cases received in the dosage of 16 vials. 
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FIGURE 23- DOSAGE OF ASV NEEDED 
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Table 12-  FREQUENCY OF OCCURRENCE OF INDIVIDUAL 
PARAMETERS 
S.No Clinical parameter  Frequency  
 (n) 
1. Ptosis  50 
 
2. EOM restriction 47 
 
3. Neck muscle weakness 43 
 
4. Muscle weakness 37 
 
 
              In our study group, all the 50 patients had ptosis, 43 patients had neck 
muscle weakness, 37 patients had muscle weakness. 
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FIGURE 24 - FREQUENCY OF OCCURRENCE OF INDIVIDUAL 
CLINICAL PARAMETERS 
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TABLE 13   - Respiratory failure and outcome 
 
S.No Respiratory 
failure 
Frequency of 
occurrence (n) 
 
Recovery  Death  
1. 
 
Yes 32(64%) 25(58%) 7(100%) 
2. 
 
No  18(36%) 18(42%) 0(0%) 
  
       In our study group, about  32 patients had respiratory failure. All the 
patients were given mechanical ventilator support. Number of death caused by 
respiratory failure is statistically significant( P value -0.02) 
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FIGURE 25 - RESPIRATORY FAILURE AND OUTCOME 
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TABLE 14-   DURATION OF VENTILATORY SUPPORT AND 
OUTCOME 
 
S.No Ventilator 
support 
duration 
 
Frequency Recovery  Death  Total  
1. <3 days 
 
13 
40.6% 
 
13 
48.1% 
0 13 
2. 3-6 days 
 
13 
40.6% 
 
11 
49.4% 
2 
28.6% 
13 
3. >7 days 
 
6 
18.7% 
 
1 5 
71.4% 
6 
Total   
 
32 
100% 
 
26 7 32 
 
        
       In our study, 32 patients needed ventilator support.  Among them, 6 patients 
was on ventilator for more than 7 days and out of this 5 patients were died. 
Association between duration of mechanical ventilation and outcome is 
statistically significant (P value -0.012) 
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FIGURE 26 -  DURATION OF VENTILATOR SUPPORT AND 
OUTCOME 
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TABLE 15- COMPARISON OF OUTCOME WITH DEVELOPMENT OF 
VAP 
S.No. Ventilator 
support duration 
 
 
VAP 
 
Recovery  
 
Death  
 
Total  
1. <3 days 1 1 0 1 
 
2. 3-6 days 5 4 1 5 
 
3. >7 days 6 2 4 6 
 
Total  12   12 
 
 
Association between the VAP and outcome was not statistically significant. 
Patients on ventilation for more than 7 days developed VAP. Thus the 
prolonged ventilatory support exposes the patient for acquiring VAP. 
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FIGURE 27-  COMPARISON OF VENTILATOR SUPPORT AND 
OUTCOME 
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Table 16-  Duration of stay in hospital and outcome 
 
S.No Duration of stay Frequency  
(n) 
 
Recovery  Death  
1. <3 days 
 
1 
2% 
 
1 
2% 
0 
Nil 
2. 3-5 days 
 
29 
58% 
 
28 
56% 
1 
2% 
3. 5-7 days 
 
13 
26% 
 
10 
20% 
3 
6% 
4. >7 days 
 
7 
14% 
 
4 
8% 
3 
6% 
Total   
 
50 43 
 
7 
  
                In our study, the total number of patients stayed in the hospital for 
more than 7 days was about 7 patients, of this 3 patients were died. This was 
statistically significant( p<0.05) 
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Figure 28-    Duration of stay in hospital and outcome 
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DISCUSSION 
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DISCUSSION 
       Our study was conducted in the patients admitted with neurotoxic 
manifestations of  snake bite. Our study group size was 50. Patients included in 
the study was closely monitored for the parameters listed in methodology. All 
the 50 patients was followed up till the discharge of the patients and the 
outcome was observed in terms of either recovery or death. Outcome analysis 
was done in comparison with parameters like type of snake, site of bite,time 
delay in reaching the hospital,amount of ASV needed, respiratory failure, 
duration of  ventilatory support, VAP, duration of stay in hospital using  Chi 
square test and Fisher Exact test. Following were the main observations from 
our study conducted in the snake bite patients (n-50). 
 
AGE AND SEX DISTRIBUTION: 
          Out of the 50 patients, maximum number of cases were in the age group 
between 40-60 years  as observed in the frequency distribution table. Maximum 
percentage ( 35%) of the cases were in the age group between 40-60 years. 
Similarly a prospective study conducted in Andhra Pradesh by Brundha G et al 
showed that 71% of the patients were in the age group between 30-50 years.  
Working  age  group peoples were mainly affected. Target age group people 
should undergo proper health education and personal protection in the working 
premises. 
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SEX DISTRIBUTION: 
          Out of the 50 patients included in the study, 30 (65%) of the patients were 
found to be male, 20 (40%) were females. There is gender predilection for 
males as compared to that of females. But the correlation between the sex and 
outcome was not stastically significant (p value >0.05). A study conducted in 
Andhra Pradesh showed male preponderance.  Age and sex did not have any 
influence on the outcome.( P value >0.05) 
 
OCCUPATION AND PLACE: 
          35 out of 50 patients were agricultural workers. 70% of the patients were 
from the agricultural sector and the remaining 30% of them were unskilled 
labourers and others. Maximum number of cases were from the rural  area 
where agriculture is the sole occupation. Mortality was equally distributed 
among the agricultural and non- agricultural workers. It is stastistically 
insignificant. (P >0.05).   Prevalence of  Snake bite is common among the 
agricultural workers. There is increased risk of snake bite among the farmers, 
plantation workers.    
           Out of 50 patients, 39 patients were from rural area and the remaining 11 
were from urban area. 78% of the patients were from rural area. Similar 
retrospective study in Chandigarh by Sharma N et al  found out that 82.4% of 
the cases were reported  from the rural areas. Among these 61% of the bites 
occurred during the night time. In rural areas, access to health care providers is 
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minimal and the awareness about the preventive measures were also lacking in 
the individuals. 
         In our study, we highlighted the health education  regarding the preventive 
measures and early access to health care providers will reduce the mortality 
among the individuals.  
  
SITE OF BITE AND FIRST AID MEASURES: 
            In our study, 32 patients were bitten in the lower limb and 14 patients in 
the upper limb. This shows that most of the cases were bitten in the lower limb. 
This is not statistically significant. Snakes have the easy accessibility to bite the 
lower limbs than the upper limb. A study in West Bengal by  Hati AK et al(3)  
showed that the  53% of bites were in the lower limb and that too in night time 
during  sleep.  
            In our study, among the 50 patients, 22 (44%) patients were undergone 
local procedures in the form of cutting, ligature, sucking the wound. A similar   
retrospective study  in Singapore done by Tan HH (51)  for 5 years duration  
observed that 15% (8) of the victims used the tourniquet as the first procedure, 
2%(1) of the person was  treated by cutting the wound and 6%(3) of the persons 
were treated by sucking the wound.  This is due to the false beliefs and 
traditional methods followed in our country.  In our study, we highlighted the 
early treatment in the hospital and the health education  to the people and 
eradicating the false beliefs reduces the mortality among the snake bite victims. 
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TIME DELAY IN REACHING THE HOSPITAL: 
           In our study, 21 patients were reached the hospital within 3 hours, 12 
patients in the duration between 3-6 hours and 17 patients reached the hospital 
in the duration of about more than 6 hours. Among the 17 patients who reached 
the hospital late, 5 patients were dead. This shows that the time delay in seeking 
the hospital treatment increases the mortality among the victims. This is 
statistically significant.(p <0.05). Nigam et al reported that 14 persons were died 
due to the delay in reaching the hospital, they were admitted in the hospital after 
receiving some traditional treatment in the time duration of about > 6 hours. 
Thus there should be some standard protocol to be followed even in the primary 
health care centres to prevent the mortality among the individuals who seek late 
admission the hospital. 
 
TYPE OF SNAKE: 
         In our study group, Cobra (n-24 cases) was the frequent cause  
of snake bite. Remaining 21 cases were bitten by krait and 11 cases by viper. 
But the type of snake bitten by the individual and the outcome has no 
correlation i.e, it is statistically insignificant with P value of about 0.614. 
Similar study done in Nepal by Sharma SK et al(22), observed that the most 
common bite is due to Cobra, they showed that 58% of the patients were bitten 
by the cobra.  
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CLINICAL FEATURES IN NEUROTOXIC SNAKE BITE: 
       In our study group, 100% of the patients were having ptosis as the 
commonest manifestation of neurotoxic bite. 94% ( n-47) of the patients were 
having EOM restriction, 86% (n-43) of the patients were having neck muscle 
weakness, 74% (n-37) of the patients were having muscle weakness and  64% 
(n-32) of the patients were having respiratory failure. According to Nigam et al 
85% of the patients were having ptosis, 43% of the patients having EOM 
restriction, 71% of the  patients were having palatal palsy, 42% with respiratory 
failure,7% with muscle weakness.  
    Among them, 32 patients had respiratory failure in our study, all of them 
were put on mechanical ventilation. Respiratory failure affected the outcome of 
the individuals. 6 patients was on mechanical ventilation for more than 7 days 
and out of this 5 patients died. Association between the duration of mechanical 
ventilation and the outcome is statistically significant with   
p value- 0.012. 
       Respiratory failure has significantly correlated with the outcome and the 
duration of MV and outcome is also significant. Thus the respiratory failure 
patients were to be closely observed to prevent the mortality.  
 
VAP AND OUTCOME ANALYSIS: 
          Prolonged ventilatory support had increased risk for VAP ( ventilator 
associated pneumonia). Out of the 32 patients on ventilator, 12 patients 
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developed VAP. In our study group, VAP were developed in the patients who 
were on ventilator for more than 4 days. Correlation between the VAP and 
outcome was statistically analysed using the Chi Square test, but the association 
is not statistically significant (p value>0.05)   
 
AMOUNT OF ASV NEEDED: 
           In our study group, 15 cases were received 16 vials of ASV, 35 cases 
were received 23 vials of ASV. If the patient had come earlier to the hospital  
had better prognosis and the amount of ASV need  for the treating the victim  
was also low. There should be some standard protocol for treating the patients, 
that should be strictly followed to reduce the mortality among the individuals. A 
study in West Bengal by Ghosh et el(55) proved that the protocol treatment 
showed a marked decrease of about 66% in the amount of ASV administration 
and with 24% reduction in mortality. ASV received in the early hours of bite  
with the correct dosage has high influence over the outcome of the individual 
and has significant reduction in mortality. 
            Out of 50 patients in our study group, 24 patients were responded to 
neostigmine, neostigmine responders were bitten by the cobra. This is because 
of the pre-synaptic action of neostigmine. 
 
 
  
 
 
 
 
   CONCLUSION 
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CONCLUSION 
 
Following results were concluded from the study: 
1.Majority of the victims were in the age group between 41-60 years. 
          2.Males were most commonly affected in our study 
3.Most of the individuals were from the rural area 
4. Most of them were agricultural workers, because snake bite is the 
occupational hazard among the farmers and plantation workers. 
5. Cobra is the most common bite encountered in our study. These 
patients were responded to neostigmine 
6. Number of deaths due to Cobra were comparatively high in our study, 
but it has no significant effect on outcome. Because cobra is the most 
poisonous among all snakes.  
7. Lower limb was the most common site of bite in our study group. 
8.Ptosis is the most common presentation in the victims, about 100% i.e, 
all the patients were having ptosis 
9. Time delay in seeking the hospital premises had significant effect on 
the outcome of the individual, this has to be reduced by health education 
and better transport facilities in the rural areas. 
10. Most of the victims needed about 23 vials of ASV 
11.Respiratory failure significantly affects the outcome of the individual, 
is the most important risk factor for mortality 
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12. Duration of ventilator support has significant effect on the outcome of 
the individual. 
13. Chance of getting Ventilator associated pneumonia is dependent on 
duration of ventilator support but it is not related to the outcome. 
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ANNEXURES 
 
 
 
 
 
 
 
 
 
“CLINICAL PROFILE AND OUTCOME OF PATIENTS WITH 
NEUROTOXIC SNAKE BITE” 
PROFORMA 
 
Name:      Age/Sex: 
Address:      Occupation: 
  
SYMPTOMS: 
 
Double vision 
Drooping of eyelids 
Descending paralysis 
Weakness of Neck flexors 
Respiratory failure 
 
 
SNAKE BITE: 
 
Site of bite  
Time delay in reaching 
hospital 
 
Neostigmine 
responder/non 
responder 
 
Dosage of ASV 
needed  
 
 
 
PAST HISTORY: 
COPD  
CVA  
CKD  
HYPOTYHROIDISM  
MYASTHENIA GRAVIS  
KNOWN  C/O MUSCULAR DYSTROPHY  
 
PERSONAL HISTORY: 
SMOKING 
ALCOHOL 
 
GENERAL EXAMINATION: 
GCS  
 
VITAL SIGNS: 
       PR- 
       BP- 
       RR- 
 
SYSTEMIC EXAMINATION: 
 
CVS: 
 
RS: 
 
ABDOMEN: 
CNS: 
 RIGHT LEFT 
PUPILS: 
     Size 
     Light reflex 
  
EXTRAOCULAR 
MOVEMENTS: 
      Adduction 
      Abduction 
      Elevation 
      Depression 
 
      Nystagmus/ ptosis 
  
NECK FLEXORS   
 
RESPIRATORY  
FAILURE: 
     SBCT 
  
UPPER LIMB 
POWER: 
           
  
LOWER LIMB 
POWER: 
      
  
 
 
 
 
 INVESTIGATIONS: 
 
COMPLETE HEMOGRAM 
RFT, LFT 
SERUM ELECROLYTES 
ECG 
CXR PAVIEW 
 
 
NEUROTOXIC MANIFESTATION- ASSESSMENT: 
 
Time delay 
in reaching 
hospital 
Neostigmine 
responder / 
nonresponder       
Dosage of 
ASV 
needed 
Respiratory 
failure 
        
Outcome 
Ventilatory support 
R
ec
o
v
er
y
 
D
ea
th
 
 
 
 
 
If yes, No. of 
days on 
ventilatory 
support 
                  
 
 
 
 
 
 
  
 
 
INFORMATION SHEET 
 
We are conducting a study on “CLINICAL PROFILE AND OUTCOME 
OF PATIENTS WITH NEUROTOXIC SNAKE BITE” among patients 
attending Rajiv Gandhi Government General Hospital, Chennai and for that your 
specimen may be valuable to us. 
 
           The purpose of this study is to assess the occurrence of  respiratory 
paralysis in patients with neuro toxic snake bite with following factors: Age, Sex, 
site of bite, geographical location, time delay in reaching hospital, neostigmine 
responder and non responder,dosage of ASV needed, Need for Mechanical 
ventilation and final Outcome on follow up. 
 
We are selecting certain cases and if you are found eligible, we may be 
using your blood samples to do certain tests which in any way do not affect your 
final report or management. 
 
The privacy of the patients in the research will be maintained throughout the 
study. In the event of any publication or presentation resulting from the research, 
no personally identifiable information will be shared. 
 
Taking part in this study is voluntary. You are free to decide whether to 
participate in this study or to withdraw at any time; your decision will not result in 
any loss of benefits to which you are otherwise entitled. 
 
The results of the special study may be intimated to you at the end of the 
study period or during the study if anything is found abnormal which may aid in 
the management or treatment. 
 
 
 
 
Signature of Investigator Signature of Participant 
 
Date : 
Place :
  
 
  
 
 
 
 
 
MASTER CHART 
 
 
 
 
 
 
“CLINICAL PROFILE AND OUTCOME OF PATIENTS WITH NEUROTOXIC SNAKE BITE” 
MASTER CHART (PART-I) 
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1 60 M  L FOOT SINGLE RURAL AGRI COBRA 6 YES YES <20 MIN 16 YES 
2 34 M  L HAND SINGLE RURAL 
 
AGRI 
 
VIPER 7 YES YES >20 MIN 16 NO 
3 34 F R FOOT SINGLE RURAL NON-AGRI KRAIT 2 NO NO <20 MIN 23 NO 
4 52 M  L THUMB SINGLE URBAN NON-AGRI KRAIT 1 NO NO <20 MIN 16 NO 
5 35 F R FOOT SINGLE RURAL AGRI COBRA 8 YES YES <20 MIN 23 YES 
6 55 M  R THUMB SINGLE RURAL AGRI VIPER 10 YES YES >20 MIN 23 NO 
7 45 M  RGREAT TOE SINGLE RURAL AGRI COBRA 6 1/2 YES YES <20 MIN 23 YES 
8 28 M  L ARM SINGLE RURAL AGRI COBRA 12 YES YES <20 MIN 23 YES 
9 22 F L FACE SINGLE RURAL AGRI COBRA 1/2. NO YES <20 MIN 16 YES 
10 25 M  L CHEEK SINGLE RURAL AGRI COBRA 13 YES YES <20 MIN 23 YES 
11 30 M  L FOREARM SINGLE URBAN NON-AGRI VIPER 3 NO YES >20 MIN 16 NO 
12 40 F L FOOT SINGLE RURAL AGRI KRAIT 7 YES NO <20 MIN 23 NO 
13 32 F R FOREARM SINGLE URBAN NON-AGRI KRAIT 10 YES NO <20 MIN 23 NO 
14 30 F R ARM  SINGLE RURAL AGRI COBRA 2 NO YES <20 MIN 16 YES 
15 31 M  R LEG SINGLE RURAL NON-AGRI KRAIT 6 NO NO <20 MIN 16 NO 
16 60 M  L THIGH SINGLE URBAN AGRI COBRA 13 YES YES <20 MIN 23 YES 
17 22 F L FACE MULTIPLE URBAN AGRI COBRA 14 YES YES <20 MIN 23 YES 
18 32 M  L HAND SINGLE RURAL NON-AGRI KRAIT 4 NO NO <20 MIN 23 NO 
19 28 M  L LITTLE SINGLE RURAL AGRI VIPER 6 NO YES >20 MIN 23 NO 
TOE 
20 25 M  R HAND SINGLE URBAN NON-AGRI KRAIT 1 NO NO <20 MIN 16 NO 
21 24 M  R ARM  SINGLE RURAL AGRI COBRA 6 1/2 NO YES <20 MIN 23 YES 
22 17 F L THIGH SINGLE URBAN AGRI COBRA 15 YES YES <20 MIN 23 YES 
23 65 M  
L 4TH 
FINGER SINGLE RURAL AGRI COBRA 
12 
1/2 YES YES <20 MIN 23 YES 
24 48 F 
R 
2NDFINGER SINGLE RURAL AGRI COBRA 3 NO YES <20 MIN 16 YES 
25 25 F 
R3RD 
FINGER SINGLE RURAL AGRI VIPER 7 1/2 YES YES >20 MIN 23 NO 
26 39 M  R FOOT SINGLE URBAN NON-AGRI KRAIT 4 NO NO <20 MIN 16 NO 
27 38 M  R THIGH SINGLE RURAL AGRI KRAIT 3 NO NO <20 MIN 23 NO 
28 75 F 
R GREAT 
TOE SINGLE URBAN AGRI COBRA 10 YES YES <20 MIN 23 YES 
29 45 M  R2NDFINGER SINGLE RURAL AGRI VIPER 3 NO YES >20 MIN 16 NO 
30 25 F 
L3RD 
FINGER SINGLE RURAL NON-AGRI COBRA 1/2. NO YES <20 MIN 23 YES 
31 19 M  R CHEEK SINGLE RURAL AGRI KRAIT 5 NO NO <20 MIN 23 NO 
32 20 M  R FOREARM MULTIPLE RURAL AGRI COBRA 3 YES YES <20 MIN 23 YES 
33 47 F R THUMB SINGLE RURAL NON-AGRI VIPER 1 1/2 NO YES <20 MIN 16 NO 
34 40 F 
R LITTLE 
TOE SINGLE RURAL AGRI KRAIT 1/2. NO NO <20 MIN 16 NO 
35 37 F R4THFINGER SINGLE RURAL AGRI COBRA 3 YES YES <20 MIN 23 YES 
36 50 M  R HAND SINGLE RURAL NON-AGRI VIPER 2 NO YES >20 MIN 23 NO 
37 63 M  R FOOT SINGLE RURAL NON-AGRI COBRA 3 NO YES <20 MIN 23 YES 
38 52 M L THUMB SINGLE RURAL AGRI KRAIT 4 NO NO <20 MIN 23 NO 
39 55 M 
R3RD 
FINGER SINGLE RURAL AGRI COBRA 1 1/2 NO YES <20 MIN 16 YES 
40 36 M L THUMB SINGLE RURAL AGRI COBRA 4 NO YES <20 MIN 23 YES 
41 30 M R2NDFINGER SINGLE RURAL AGRI COBRA 6 NO YES <20 MIN 23 YES 
42 45 F L LEG SINGLE URBAN NON-AGRI KRAIT 5 YES NO <20 MIN 23 NO 
43 56 F R4THFINGER SINGLE RURAL AGRI VIPER 2 NO YES >20 MIN 23 NO 
44 76 M R2NDFINGER SINGLE RURAL AGRI VIPER 10 YES YES >20 MIN 23 NO 
45 61 F R THUMB MULTIPLE RURAL AGRI COBRA 3 NO YES <20 MIN 23 YES 
46 47 M 
R LITTLE 
TOE SINGLE RURAL NON-AGRI KRAIT 6 YES NO <20 MIN 23 NO 
47 56 F R LEG SINGLE RURAL AGRI KRAIT 2 YES NO <20 MIN 16 NO 
48 52 M R ARM  SINGLE RURAL AGRI COBRA 7 1/2 YES YES <20 MIN 23 YES 
49 55 M L THIGH SINGLE URBAN NON-AGRI COBRA 3 NO YES <20 MIN 23 YES 
50 36 F L FOREARM SINGLE RURAL AGRI VIPER 4 NO YES >20 MIN 23 NO 
 
 
 
 
 
 
 
 
 
 
 
 
“CLINICAL PROFILE AND OUTCOME OF PATIENTS WITH NEUROTOXIC SNAKE BITE” 
MASTER CHART (PART-II) 
S.NO. PTOSIS EOM 
NECK 
MUSCLE 
WEAKNESS GAG 
MUSCLE 
WEAKNESS 
RESPIRATORY 
FAILURE 
VENTILATORY 
SUPPORT 
NO.OF 
DAYS 
IN MV VAP 
K+ 
LEVEL 
DURATION 
OF STAY OUTCOME 
1 YES RESTRICTED YES ABSENT YES YES YES 2 NO 4.5 4 RECOVERED 
2 YES RESTRICTED YES PRESENT NO NO NO NIL NO 4 2 RECOVERED 
3 YES RESTRICTED YES ABSENT YES YES YES 2 YES 4.6 7 RECOVERED 
4 YES RESTRICTED NO PRESENT NO NO NO NIL NO 4 3 RECOVERED 
5 YES RESTRICTED YES ABSENT YES YES YES 5 YES 4.3 6 RECOVERED 
6 YES RESTRICTED YES ABSENT YES YES YES 7 YES 4.2 7 DEATH 
7 YES RESTRICTED YES ABSENT YES YES YES 3 NO 4.7 5 RECOVERED 
8 YES RESTRICTED YES ABSENT YES YES YES 6NIL YES 4 6 RECOVERED 
9 YES FULL NO PRESENT NO NO NO 10 YES 4.5 3 DEATH 
10 YES RESTRICTED YES ABSENT YES YES YES NIL NO 5 10 RECOVERED 
11 YES FULL YES ABSENT YES NO NO NIL NO 4.6 4 RECOVERED 
12 YES RESTRICTED YES PRESENT YES YES YES 3 NO 4.3 6 RECOVERED 
13 YES RESTRICTED YES ABSENT YES YES YES 3 NO 4.3 3 RECOVERED 
14 YES FULL NO PRESENT NO NO NO NIL NO 4.2 4 RECOVERED 
15 YES RESTRICTED YES PRESENT NO NO NO NIL NO 4.1 4 RECOVERED 
16 YES RESTRICTED YES ABSENT YES YES YES 6 YES 4 6 DEATH 
17 YES RESTRICTED YES ABSENT YES YES YES 6 NO 4.3 8 RECOVERED 
18 YES RESTRICTED YES ABSENT YES YES YES 2 NO 4.2 5 RECOVERED 
19 YES RESTRICTED YES PRESENT NO NO NO NIL NO 4.8 3 RECOVERED 
20 YES RESTRICTED YES PRESENT NO NO NO NIL NO 4.7 3 RECOVERED 
21 YES RESTRICTED YES ABSENT YES YES YES 6 NO 4.5 8 RECOVERED 
22 YES RESTRICTED YES ABSENT YES YES YES 7 YES 3.6 7 RECOVERED 
23 YES RESTRICTED YES ABSENT YES YES YES 7 NO 4.2 8 RECOVERED 
24 YES RESTRICTED NO PRESENT NO NO NO NIL NO 4.1 6 DEATH 
25 YES RESTRICTED YES ABSENT YES YES YES 4 NO 4 6 RECOVERED 
26 YES RESTRICTED YES ABSENT YES NO NO NIL NO 4.3 4 RECOVERED 
27 YES RESTRICTED YES ABSENT YES YES YES 8 YES 4.2 8 DEATH 
28 YES RESTRICTED YES ABSENT YES YES YES 4 NO 4.5 4 RECOVERED 
29 YES RESTRICTED YES ABSENT YES NO NO NIL NO 4.3 3 RECOVERED 
30 YES RESTRICTED NO PRESENT NO NO NO NIL NO 4.2 5 RECOVERED 
31 YES RESTRICTED YES ABSENT YES YES YES 6 NO 4.5 6 RECOVERED 
32 YES RESTRICTED YES ABSENT YES YES YES 4 NO 4.6 4 RECOVERED 
33 YES RESTRICTED YES PRESENT NO NO NO NIL NO 4.33 3 RECOVERED 
34 YES RESTRICTED NO PRESENT NO NO NO NIL NO 4.9 5 RECOVERED 
35 YES RESTRICTED YES ABSENT YES YES YES 3 NO 5 7 RECOVERED 
36 YES RESTRICTED YES ABSENT NO NO NO NIL NO 3.9 3 RECOVERED 
37 YES RESTRICTED YES ABSENT YES NO NO NIL NO 4 4 RECOVERED 
38 YES RESTRICTED YES PRESENT YES YES YES 2 NO 4.7 4 RECOVERED 
39 YES RESTRICTED NO ABSENT NO NO NO NIL NO 4.3 3 RECOVERED 
40 YES RESTRICTED YES ABSENT YES YES YES 3 YES 4.8 6 RECOVERED 
41 YES RESTRICTED YES ABSENT YES YES YES 5 YES 4.1 7 RECOVERED 
42 YES RESTRICTED YES ABSENT YES YES YES 4 NO 4.9 4 RECOVERED 
43 YES RESTRICTED YES ABSENT YES NO NO NIL NO 4.8 4 RECOVERED 
44 YES RESTRICTED YES ABSENT YES YES YES 7 YES 4.5 10 DEATH 
45 YES RESTRICTED YES ABSENT YES YES YES 2 NO 4.6 5 RECOVERED 
46 YES RESTRICTED YES ABSENT YES YES YES 3 NO 3.8 5 RECOVERED 
47 YES RESTRICTED YES ABSENT YES YES YES 2 NO 4 4 RECOVERED 
48 YES RESTRICTED YES ABSENT YES YES YES 10 YES 4.5 10 DEATH 
49 YES RESTRICTED YES ABSENT YES YES YES 4 NO 4.7 5 RECOVERED 
50 YES RESTRICTED YES ABSENT YES YES YES 3 NO 4 4 RECOVERED 
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